Literature DB >> 20371033

Major depressive disorder treatment guidelines in China.

Mingyuan Zhang1.   

Abstract

Depression is a common illness in the Chinese population, but very few people with depression seek treatment or are properly diagnosed and treated when they do visit a medical professional. One potential result of this situation is that suicidality is higher than it might be if more people with depression received appropriate treatment. When patients do receive pharmacotherapy for depression, benzodiazepines and tricyclic antidepressants are overprescribed. The Chinese psychiatric establishment has published a sufficient guideline outlining treatment strategies for depressive disorders, but education for psychiatrists and general practitioners is needed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371033     DOI: 10.4088/JCP.9058se1c.06gry

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

1.  Course of late-life depression in China is chronic and unremitting.

Authors:  Kimberly A Van Orden; Shulin Chen; Alisa O'Riley; Yeates Conwell
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-02       Impact factor: 3.485

Review 2.  Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder.

Authors:  Ashwin A Patkar; Chi-Un Pae
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

3.  Evidence-based treatment for depressive disorder.

Authors:  Chi-Un Pae
Journal:  Psychiatry Investig       Date:  2015-03-18       Impact factor: 2.505

4.  Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study.

Authors:  Young Sup Woo; Roger S McIntyre; Jung-Bum Kim; Min-Soo Lee; Jae-Min Kim; Hyeon Woo Yim; Tae-Youn Jun
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-11-30       Impact factor: 2.582

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.